Rowan and Sentrimed University®IN The Biofarmaceutical Company on the clinical stage focused on the development of safer, orally administered oncology therapy, today announced the results from Nation financed by® In patients with oral squamous cell carcinoma (OSCC). The main candidate for the company’s product, Masl, is innovative therapeutic Lekine Licensed at the University of Rowan. […]
Tag Archives: trial
Researchers at the University of Texas MD Anderson Cancer Center will present promising clinical trial results in three mini -deposits in the American Association for Cancer Research (AACR) Annual Meeting 2025. The results include the personalized treatment of the combination combination for large intestinal cancer, the use of radiotherapy to av systemic kidney cancer, as […]